EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study

Adefounke Prudencia Adechina, Yaou Pierrot Assogba, Edmond Tchiakpe, Akadiri Yessoufou

BMC Research Notes · 2024

DOI: 10.1186/s13104-024-06809-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Research Notes, 2024. Verfasst von Adefounke Prudencia Adechina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cell Biology, Physiology and Immunology, Department of Biochemistry and Cellular Biology, Faculty of Sciences and Technology (FAST), Un…. Hauptthemen laut MEDLINE: HIV Infections, HLA-B Antigens, Drug Hypersensitivity, HIV-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antiretroviral drugs in people living with HIV-1 (PLHIV-1) often trigger side effects which may lead to discontinuation or failure of treatment. Human Leukocyte Antigen B*57:01 (HLA-B*57:01) allele is known to predict hypersensitivity reactions to Abacavir. Very few data are available on the prevalence of HLA-B*57:01 allele in PLHIV-1 in African countries. This study aimed to screen for HLA-B*57:01 allele in PLHIV-1 in Benin.

Methods

This pilot study was carried out on one hundred ten PLHIV-1 enrolled in two health facilities in Benin. Socio-demographic and clinical data were collected. Biological data were determined and HLA-B*57:01 allele was genotyped, using Single Specific Primer-Polymerase Chain Reaction in blood samples.

Results

70% of participants were female. PLHIV-1 were under TDF + 3TC + DTG (47.2%) or TDF + 3TC + EFV (57.3%). Their median age was 41 [36-48.75] years and the average CD4 + T cell count was 249 [130-381.25] cells/µl. The average viral load in treatment failure PLHIV-1 was 4.7 [3.9–5.2] Log10. At the inclusion date, twenty-nine (26.4%) PLHIV-1 under TDF + 3TC + EFV have developed hypersensitivity reactions. None of 110 patients had shown HLA-B*5701 allele.

Conclusion

Our study revealed that HLA-B*57:01 allele was very rare in PLHIV-1 in Benin, suggesting that its screening before starting the Abacavir regimen did not seem necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHLA-B AntigensDrug HypersensitivityHIV-1HumansPilot ProjectsFemaleMaleBeninAdultMiddle AgedAnti-HIV AgentsAllelesDideoxynucleosidesCyclopropanesDideoxyadenosineAbacavir

Stichwörter der Autor:innen

AbacavirAntiretroviral therapyBeninHIV-1HLA-B*57:01Hypersensitivity reactions

Substanzen

HLA-B AntigensAnti-HIV AgentsDideoxynucleosidesCyclopropanesDideoxyadenosineAbacavirHLA-B*57:01 antigenHLA-B57 antigen

Autor:innen und Institutionen

  • Laboratory of Cell Biology, Physiology and Immunology, Department of Biochemistry and Cellular Biology, Faculty of Sciences and Technology (FAST), University of Abomey-Calavi (UAC), Cotonou, 01 BP 526, Benin.
  • Institute of Applied Biomedical Sciences (ISBA), CBRSI, MESRS, Cotonou, 01 BP 918, Bénin.
  • Centre de Recherche pour la lutte contre les Maladies Infectieuses Tropicales (CReMIT), University of Abomey-Calavi (UAC), Cotonou, 01 BP 526, Benin.
  • Laboratoire de Référence du Programme Santé de Lutte contre le Sida (PSLS), Cotonou, BP, 1258, Benin.
  • Laboratory of Cell Biology, Physiology and Immunology, Department of Biochemistry and Cellular Biology, Faculty of Sciences and Technology (FAST), University of Abomey-Calavi (UAC), Cotonou, 01 BP 526, Benin. akadiri.ye…
  • Institute of Applied Biomedical Sciences (ISBA), CBRSI, MESRS, Cotonou, 01 BP 918, Bénin. akadiri.yessoufou@gmail.com.

Zitieren

APA

Adechina, A. P., Assogba, Y. P., Tchiakpe, E., & Yessoufou, A. (2024). Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study. BMC Research Notes. https://doi.org/10.1186/s13104-024-06809-5

Vancouver

Adechina AP, Assogba YP, Tchiakpe E, Yessoufou A. Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study. BMC Research Notes. 2024. doi:10.1186/s13104-024-06809-5

BibTeX
@article{Adechina2024,
  author = {Adechina, Adefounke Prudencia and Assogba, Yaou Pierrot and Tchiakpe, Edmond and Yessoufou, Akadiri},
  title = {Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study},
  journal = {BMC Research Notes},
  year = {2024},
  doi = {10.1186/s13104-024-06809-5}
}
Kostenlos starten →